Laura Lovett
The country's FinnGen Project seeks to use its unique population bottleneck and cohesive health records to drive genetic insights.
CEO Sean Duffy discusses clinical validation, digital therapeutics and the new opportunity for a digital provider.
The startup launched three new test kits, which will test for conditions such as chlamydia, gonorrhea and syphilis.
The company exclusively announced to MobiHealthNews its plans to create a tool kit for providers, payers and pharmas.
Amgen Ventures, Celegene, Echo Health Ventures, Alexandria Venture Investments and Gary Loveman also participated.
The companies will be using DEARhealth's platform, which integrates AI into EHRs to predict health outcomes.
Pharma companies also continued to explore the promises of digital therapeutics.
The class includes startups involved in workflow management systems, remote patient monitoring systems, clinical trial data tools and augmented reality education.
In a small JMIR study, 52% of participants were very or extremely satisfied with the program.
In July, MobiHealthNews will focus on how pharma companies are using digital tools for R&D, real-world evidence collection and exploring new therapeutics.